Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on American Well (AMWL – Research Report), BridgeBio Pharma (BBIO – Research Report) and Idexx Laboratories (IDXX – Research Report).
American Well (AMWL)
In a report released today, Ryan MacDonald from Needham reiterated a Hold rating on American Well. The company’s shares closed last Thursday at $1.34, close to its 52-week low of $0.93.
According to TipRanks.com, MacDonald is a 5-star analyst with an average return of
Currently, the analyst consensus on American Well is a Hold with an average price target of $2.18, which is a 98.2% upside from current levels. In a report issued on October 20, Truist Financial also maintained a Hold rating on the stock.
See Insiders’ Hot Stocks on TipRanks >>
BridgeBio Pharma (BBIO)
In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on BridgeBio Pharma. The company’s shares closed last Thursday at $26.92.
According to TipRanks.com, Buren is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for BridgeBio Pharma with a $46.14 average price target.
Idexx Laboratories (IDXX)
In a report released today, Nathan Rich from Goldman Sachs maintained a Buy rating on Idexx Laboratories. The company’s shares closed last Thursday at $419.44.
According to TipRanks.com, Rich is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Idexx Laboratories with a $508.75 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AMWL:
- Amwell backs Fy23 revenue view of $257M-$263M, consensus $259.6M
- Amwell reports Q3 EPS (48c), consensus (21c)
- Amwell, Leidos selected by U.S. Defense Health Agency for ‘Digital First’ effort
- Amwell, Nestle Health Science team on digital solutions for patients’ health
- Amwell and HealthGorilla announce new lab capability with Converge platform
